Chang-Ming Huang Selected Research

Gastrectomy

12/2022	Indications for Adjuvant Chemotherapy in Stage II Gastric Cancer After D2 Gastrectomy-A Chinese Multicenter Study.
11/2022	Comparison of long-term outcomes after robotic versus laparoscopic radical gastrectomy: a propensity score-matching study.
11/2022	Surgical Outcomes, Technical Performance, and Surgery Burden of Robotic Total Gastrectomy for Locally Advanced Gastric Cancer: A Prospective Study.
10/2022	Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: A large sample analysis.
1/2022	Assessment of the short-term outcomes of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A prospective single-armed clinical trial.
1/2022	A matched cohort study of the failure pattern after laparoscopic and open gastrectomy for locally advanced gastric cancer: does the operative approach matter?
1/2022	A good preoperative immune prognostic index is predictive of better long-term outcomes after laparoscopic gastrectomy compared with open gastrectomy for stage II gastric cancer in elderly patients.
1/2022	Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matching.
11/2021	Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based on propensity matching.
10/2021	Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang-Ming Huang Research Topics

Disease

169	Stomach Neoplasms (Stomach Cancer) 12/2022 - 09/2003
64	Neoplasms (Cancer) 12/2022 - 12/2004
17	Neoplasm Metastasis (Metastasis) 05/2022 - 12/2004
9	Inflammation (Inflammations) 11/2021 - 03/2017
9	Adenocarcinoma 01/2021 - 05/2016
9	Flatulence 04/2017 - 05/2011
6	Carcinoma (Carcinomatosis) 01/2021 - 12/2004
5	Lymphatic Metastasis 01/2020 - 10/2009
4	Hemorrhage 01/2022 - 01/2018
3	Sarcopenia 10/2020 - 07/2017
2	Neuroendocrine Carcinoma 01/2021 - 01/2019
2	Anastomotic Leak 01/2019 - 04/2017
2	Carcinogenesis 01/2019 - 03/2016
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 04/2017
2	Pneumonia (Pneumonitis) 01/2018 - 12/2017
2	Frailty 01/2018 - 03/2017
2	Postoperative Hemorrhage 10/2017 - 05/2015
1	Microsatellite Instability 08/2022
1	Rectal Neoplasms (Rectal Cancer) 12/2021
1	Linitis Plastica 10/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2021
1	Signet Ring Cell Carcinoma 01/2021
1	Intraoperative Complications 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 07/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 07/2020
1	Postoperative Pain 02/2020
1	Wounds and Injuries (Trauma) 02/2020
1	Margins of Excision 12/2019
1	Intraabdominal Infections 05/2019
1	Rupture 01/2019
1	Pathologic Processes 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Pain (Aches) 10/2017

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2016
7	AlbuminsIBA 11/2021 - 09/2003
5	Circular RNAIBA 01/2020 - 01/2019
4	Carcinoembryonic AntigenIBA 12/2022 - 09/2018
4	Biological ProductsIBA 01/2022 - 01/2014
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2021 - 01/2020
4	C-Reactive ProteinIBA 01/2021 - 01/2019
3	Hemoglobins (Hemoglobin)IBA 12/2022 - 09/2003
3	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 01/2014
3	CateninsIBA 03/2018 - 03/2016
2	6-methyladenineIBA 05/2022 - 10/2020
2	Messenger RNA (mRNA)IBA 05/2022 - 01/2017
2	Fibrinogen (Factor I)FDA Link 11/2021 - 11/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 09/2020 - 01/2020
2	CarbohydratesIBA 01/2020 - 09/2018
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2020 - 09/2018
2	Serum AlbuminIBA 01/2019 - 01/2018
2	Cyclin-Dependent Kinase 5IBA 01/2019 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 12/2018 - 09/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ChromatinIBA 01/2022
1	Rosiglitazone (Avandia)FDA Link 01/2022
1	histidine-rich proteinsIBA 01/2022
1	Fetal Proteins (Fetoprotein)IBA 10/2021
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	apatinibIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	camrelizumabIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 12/2020
1	CEACAM1 ProteinIBA 12/2020
1	LigandsIBA 12/2020
1	Staphylococcal Protein A (Protein A)IBA 10/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Complement System Proteins (Complement)IBA 11/2019
1	Cyclin D1IBA 05/2019
1	Phosphotransferases (Kinase)IBA 05/2019
1	Protein Isoforms (Isoforms)IBA 05/2019
1	Minichromosome Maintenance Complex Component 6IBA 01/2019
1	Prealbumin (Transthyretin)IBA 01/2019
1	ribosomal protein L6IBA 01/2019
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018

Therapy/Procedure

105	Gastrectomy 12/2022 - 09/2003
59	Lymph Node Excision (Lymph Node Dissection) 12/2022 - 12/2004
22	Adjuvant Chemotherapy 12/2022 - 03/2018
16	Drug Therapy (Chemotherapy) 10/2022 - 10/2018
11	Neoadjuvant Therapy 01/2022 - 12/2017
11	Length of Stay 02/2020 - 05/2011
5	Therapeutics 12/2022 - 04/2017
4	Splenectomy 11/2020 - 05/2008
4	Operative Surgical Procedures 05/2019 - 12/2004
4	Operative Time 01/2019 - 05/2011
3	Laparotomy 01/2017 - 12/2004
2	Minimally Invasive Surgical Procedures 09/2021 - 11/2019
2	Gastroenterostomy 03/2020 - 12/2016
2	Conservative Treatment 01/2019 - 10/2013
1	Conversion to Open Surgery 11/2020
1	Blood Transfusion (Blood Transfusions) 11/2019
1	Heterologous Transplantation (Xenotransplantation) 01/2019
1	Radiotherapy 11/2018